Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dynamic learning capability and actionable knowledge creation: clinical R&D in a pharmaceutical company

Dynamic learning capability and actionable knowledge creation: clinical R&D in a pharmaceutical... This article explores the use of organizational learning mechanisms to create actionable knowledge in a pharmaceutical company. An action research based approach was used to explore the nature and issues associated with fostering the dynamic learning capability within the firm. The results indicate that dynamic learning capability is embedded and influenced by company culture, existing skills and competence, organizational structure, incentives for learning, capacity for continuous change and leadership. It is argued that enabling actionable knowledge creation is a fragile process that has to be managed with care, and is far more complex than the literature suggests. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Learning Organization Emerald Publishing

Dynamic learning capability and actionable knowledge creation: clinical R&D in a pharmaceutical company

Loading next page...
 
/lp/emerald-publishing/dynamic-learning-capability-and-actionable-knowledge-creation-clinical-00nfo7AG8N

References (41)

Publisher
Emerald Publishing
Copyright
Copyright © 2002 MCB UP Ltd. All rights reserved.
ISSN
0969-6474
DOI
10.1108/09696470210424015
Publisher site
See Article on Publisher Site

Abstract

This article explores the use of organizational learning mechanisms to create actionable knowledge in a pharmaceutical company. An action research based approach was used to explore the nature and issues associated with fostering the dynamic learning capability within the firm. The results indicate that dynamic learning capability is embedded and influenced by company culture, existing skills and competence, organizational structure, incentives for learning, capacity for continuous change and leadership. It is argued that enabling actionable knowledge creation is a fragile process that has to be managed with care, and is far more complex than the literature suggests.

Journal

The Learning OrganizationEmerald Publishing

Published: May 1, 2002

Keywords: Dynamic learning capabilities; Actionable knowledge creation; Action research; Pharmaceutical industry

There are no references for this article.